Identify access to genetic testing in Veterans with breast cancer.

Overview

Development stage

DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.

High-impact designation

Not high-impactSource: c) Not high-impact

Impact justification

Not reported

Start date

Not reported

Withheld from public reporting

Not reported

Mission

Topic area

Health and Medical

Operational functions

Clinical and medical Derived by keyword rules; see methodology

Problem the AI is intended to solve

Try to identify which Veteran with breast cancer has or does not have access to germline genetic testing from unstructured medical notes.

Expected benefits

Providers are more aware of if a Veteran has access to germline genetic testing, this helps improve the quality of care VA delivers, since it is recommended to have germline genetic testing for everyone with breast cancer.

System outputs

If the patient has access to germline genetic testing.

Technology

AI classification

Natural language processingSource: Natural Language Processing: AI that processes, interprets, and shares information in human language.

System name(s)

Not reported

Custom-developed code

No

Public source code

Not reported

Sourcing

How it was built

Developed in-houseSource: b) Developed in-house

Vendor (as reported)

Not reported

Vendors (standardized)

None on the standard list

A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.

Data and privacy

Involves PII

Not reported

Privacy Impact Assessment

Not reported

Authorization to Operate

Not reported

Demographic features

Not reported

Training and evaluation data

Not reported

Federal Data Catalog

Not reported

Governance

0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.

Potential impacts and how they were identified

Not reported